Double your impact Match My Donation
Conquering cancer requires information and dialogue. Our print and online resources make it easy to stay up-to-date on the Cancer Research Institute’s role in helping to advance cancer immunotherapy research and treatment. We also offer information especially for patients and their families, as well as for current and prospective donors.
If you would like more information, call us at (800) 99-CANCER or send us a message via our Contact Us page.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
Patients with advanced hepatocellular carcinoma (HCC), the most common form of liver cancer, can now receive PD-1 immunotherapy for treatment.
Sixteen Team CRI runners ran the 26.2 mile 2018 TCS New York City Marathon and raised an impressive total of $110,000.